Opportunity Information: Apply for RFA CK 15 001
Apply for RFA CK 15 001
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Detection and Characterization of Emerging Vector Borne Zoonotic" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.084 Prevention of Disease, Disability, and Death by Infectious Diseases.
- This funding opportunity was created on Dec 29, 2014 and posted on Dec 29, 2014.
- Applicants must submit their applications by Mar 10, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $3,600,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $550,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligibility Category Eligibility for award is a sole source foreign entity for research activities located in Indonesia. The following organization is eligible to apply Alliance for Emerging and Re Emerging Threats in Asia (ALERT) Foundation Jalan Diponegoro No.69, Jakarta 10430, Indonesia
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Detection and Characterization of Emerging Vector Borne Zoonotic" (Funding Opportunity Number RFA CK 15 001) is a discretionary funding announcement from the Centers for Disease Control and Prevention (CDC) focused on strengthening research capacity related to emerging infectious disease threats in Indonesia. Structured as a cooperative agreement, the award mechanism signals that CDC expected to have substantial involvement in the supported work, typically through collaboration, technical input, and ongoing coordination rather than functioning as a hands-off funder. The overall goal is to support research that investigates, detects, and characterizes certain human and animal diseases that are transmitted by vectors (such as mosquitoes or ticks) and diseases that can spread between animals and people (zoonoses), with attention to both environmental and clinical dimensions of these threats.
The scope of work, as described, centers on improving understanding of specified vector-borne and zoonotic diseases by combining field and laboratory research approaches. On the environmental side, this can include studying ecological and transmission drivers, vector presence and distribution, pathogen circulation in animal reservoirs, and the conditions that increase spillover risk. On the clinical side, it emphasizes activities that improve detection and characterization in people and animals, which often involves strengthening diagnostic approaches, conducting surveillance-linked studies, and analyzing clinical presentations to better distinguish these infections from other similar febrile illnesses. Taken together, the intent is to generate evidence that helps public health and animal health stakeholders in Indonesia identify emerging threats earlier, describe them more accurately, and respond with better targeted prevention and control strategies.
The funding details indicate an estimated total program funding level of $3,600,000, with an anticipated single award. Individual award amounts were expected to fall between a floor of $250,000 and a ceiling of $550,000. The opportunity did not require cost sharing or matching funds. It was categorized under CFDA 93.084, "Prevention of Disease, Disability, and Death by Infectious Diseases," which aligns with CDCs broader mission to reduce morbidity and mortality from infectious threats through surveillance, research, and applied public health action.
Eligibility for this opportunity was narrowly defined. It was a sole-source announcement restricted to a specific foreign entity conducting research activities located in Indonesia. The only organization listed as eligible to apply was the Alliance for Emerging and Re Emerging Threats in Asia (ALERT) Foundation, based in Jakarta. This sole-source approach implies CDC had a specific programmatic rationale for selecting that organization as the recipient, such as existing capacity, established partnerships, or strategic alignment with ongoing work in the country.
Key dates show the opportunity was posted and created on December 29, 2014, with an original and current closing date of March 10, 2015, and an archive date of April 9, 2015. For administrative or technical access issues, the listed point of contact was CDCs Procurement and Grants Office team (CDC/PGO) reachable by phone at 770-488-2700 or by email at pgotim@cdc.gov.
FAQs: Detection and Characterization of Emerging Vector Borne Zoonotic (RFA CK 15 001)
What is the title of this grant opportunity?
The opportunity is titled "Detection and Characterization of Emerging Vector Borne Zoonotic."
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is RFA CK 15 001.
Which federal agency is offering this opportunity?
This is a discretionary funding announcement from the Centers for Disease Control and Prevention (CDC).
What type of award mechanism is being used?
The opportunity is structured as a cooperative agreement.
What does "cooperative agreement" mean in this context?
It indicates CDC expected to have substantial involvement in the supported work, typically through collaboration, technical input, and ongoing coordination rather than acting as a hands-off funder.
What is the overall goal of the opportunity?
The goal is to strengthen research capacity related to emerging infectious disease threats in Indonesia by supporting research that investigates, detects, and characterizes specified vector-borne and zoonotic diseases, including both environmental and clinical dimensions of these threats.
What kinds of diseases are the focus of this opportunity?
The focus is on diseases transmitted by vectors (such as mosquitoes or ticks) and diseases that can spread between animals and people (zoonoses).
Where is the work expected to take place?
The announcement is focused on research activities located in Indonesia.
What is included in the environmental side of the scope of work?
Environmental research can include studying ecological and transmission drivers, vector presence and distribution, pathogen circulation in animal reservoirs, and conditions that increase spillover risk.
What is included in the clinical side of the scope of work?
Clinical activities emphasize improving detection and characterization in people and animals, which can involve strengthening diagnostic approaches, conducting surveillance-linked studies, and analyzing clinical presentations to better distinguish these infections from other similar febrile illnesses.
What is the intended public health benefit of the research?
The intent is to generate evidence that helps public health and animal health stakeholders in Indonesia identify emerging threats earlier, describe them more accurately, and respond with better targeted prevention and control strategies.
What is the estimated total program funding amount?
The estimated total program funding level is $3,600,000.
How many awards were anticipated?
The announcement anticipated a single award.
What was the expected range for individual award amounts?
Individual award amounts were expected to range from a floor of $250,000 to a ceiling of $550,000.
Is cost sharing or matching required?
No cost sharing or matching funds were required.
What is the CFDA number for this opportunity?
The opportunity was categorized under CFDA 93.084.
What is the CFDA program name associated with CFDA 93.084?
The CFDA program name is "Prevention of Disease, Disability, and Death by Infectious Diseases."
Who was eligible to apply?
Eligibility was narrowly defined as a sole-source announcement restricted to a specific foreign entity conducting research activities located in Indonesia.
Was this a competitive opportunity open to multiple applicants?
No. It was a sole-source announcement, meaning only the specifically named entity was eligible based on the information provided.
Which organization was listed as eligible to apply?
The only organization listed as eligible was the Alliance for Emerging and Re Emerging Threats in Asia (ALERT) Foundation, based in Jakarta.
What does "sole-source" imply about the selection?
It implies CDC had a specific programmatic rationale for selecting that organization as the recipient, such as existing capacity, established partnerships, or strategic alignment with ongoing work in the country.
When was the opportunity posted and created?
The opportunity was posted and created on December 29, 2014.
What was the closing date for applications?
The original and current closing date was March 10, 2015.
When was the opportunity archived?
The archive date was April 9, 2015.
Who should be contacted for administrative or technical access issues?
The listed point of contact was CDC's Procurement and Grants Office team (CDC/PGO).
What contact details were provided for CDC/PGO?
Phone: 770-488-2700. Email: pgotim@cdc.gov.
Browse more opportunities from the same category: Health
Next opportunity: Capacity Building to Prevent, Detect, and Respond to Emerging Infectious Disease Threats and Strengthen Global Health Security in Uganda
Previous opportunity: FY2015 Great Lakes Areas of Concern Land Acquisition Grants
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CK 15 001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CK 15 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Capacity Building to Prevent, Detect, and Respond to Emerging Infectious Disease Threats and Strengthen Global Health Security in Uganda Apply for RFA CK 15 003 Funding Number: RFA CK 15 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Continuing Prospective Birth Cohort Study Involving Environmental Uranium Exposure in the Navajo Nation Apply for RFA TS 13 0010501SUPP15 Funding Number: RFA TS 13 0010501SUPP15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $360,000 |
| Suicide Prevention Resource Center (SPRC) Apply for SM 15 003 Funding Number: SM 15 003 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $5,634,000 |
| Economic Studies of Immunization Policies and Practices Apply for RFA IP 15 001 Funding Number: RFA IP 15 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| MCH Pediatric Research Network Program Apply for HRSA 15 089 Funding Number: HRSA 15 089 Agency: Health Resources and Services Administration Category: Health Funding Amount: $200,000 |
| Maternal and Child Health Epidemiology Doctoral Training Program Apply for HRSA 15 109 Funding Number: HRSA 15 109 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Maternal and Child Health (MCH) Research Network on Pregnancy Related Care Program Apply for HRSA 15 090 Funding Number: HRSA 15 090 Agency: Health Resources and Services Administration Category: Health Funding Amount: $400,000 |
| Regional AIDS Education and Training Centers Apply for HRSA 15 032 Funding Number: HRSA 15 032 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| AETC National Coordinating Resource Center (NCRC) Cooperative Agreement Apply for HRSA 15 033 Funding Number: HRSA 15 033 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Conducting Public Health Research in Kenya Apply for RFA GH 15 001 Funding Number: RFA GH 15 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $15,000,000 |
| Grants to States to Support Oral Health Workforce Activities Apply for HRSA 15 052 Funding Number: HRSA 15 052 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22) Apply for PAR 15 084 Funding Number: PAR 15 084 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Academic Leadership Career Award (K07) Apply for PAR 15 078 Funding Number: PAR 15 078 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Stop Transmission of Polio (NSTOP) initiative supporting polio eradication in Africa Apply for CDC RFA GH15 1612 Funding Number: CDC RFA GH15 1612 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $18,000,000 |
| NIH Science of Behavior Change Resource and Coordinating Center (U24) Apply for RFA RM 14 017 Funding Number: RFA RM 14 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pharmacogenomics of Orofacial Pain Management (R01) Apply for RFA DE 16 001 Funding Number: RFA DE 16 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Science of Behavior Change Assay Development and Validation for Interpersonal and Social Processes Targets (UH2/UH3) Apply for RFA RM 14 018 Funding Number: RFA RM 14 018 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Rural Recruitment and Retention Analysis Cooperative Agreement Apply for HRSA 15 136 Funding Number: HRSA 15 136 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Science of Behavior Change Assay Development and Validation for Self Regulation Targets (UH2/UH3) Apply for RFA RM 14 020 Funding Number: RFA RM 14 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Science of Behavior Change Assay Development and Validation for Stress Reactivity and Stress Resilience Targets (UH2/UH3) Apply for RFA RM 14 019 Funding Number: RFA RM 14 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CK 15 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.